|
|
Volumn 142, Issue 5, 2014, Pages 584-585
|
|
Valuing value the changing role of pathologists
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
K RAS PROTEIN;
PROGESTERONE RECEPTOR;
ANEMIA;
BREAST CANCER;
CLINICAL PRACTICE;
COLON CANCER;
COMPUTERIZED PROVIDER ORDER ENTRY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
EDITORIAL;
EVIDENCE BASED MEDICINE;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEREDITARY NONPOLYPOSIS COLORECTAL CANCER;
HOSPITAL ADMISSION;
HUMAN;
PATHOLOGIST;
PATIENT CARE;
PERSONALIZED MEDICINE;
PHLEBOTOMY;
PRIORITY JOURNAL;
QUALITY CONTROL;
COST BENEFIT ANALYSIS;
DIAGNOSTIC PROCEDURE;
ECONOMICS;
EDUCATION;
HEALTH CARE DELIVERY;
PATHOLOGY;
PHYSICIAN ATTITUDE;
PROCEDURES;
CLINICAL LABORATORY TECHNIQUES;
COST-BENEFIT ANALYSIS;
DELIVERY OF HEALTH CARE;
HUMANS;
INDIVIDUALIZED MEDICINE;
PATHOLOGY, CLINICAL;
PHYSICIAN'S ROLE;
|
|
EID: 84922215414
PISSN: 00029173
EISSN: 19437722
Source Type: Journal
DOI: 10.1309/AJCPH1MW8YPKPLAR Document Type: Editorial |
|
Times cited : (7)
|
|
References (5)
|
